Management of autistic spectrum conditions in adults
| Status: |
In progress |
| Publication date: |
June 2012 |
| Wave: |
23 |
| Process: |
CG |
Topic area:
-
Mental health and behavioural conditions
|
NICE project team
| Centre for clinical practice lead: |
Christine Carson
|
| Communications manager: |
Alice Law
|
| Guidelines commissioning manager: |
Caroline Keir
|
| Guidelines coordinator: |
Jennifer Heaton
|
| Patient involvement lead: |
Sarah Chalmers
|
| Implementation lead: |
Alexa Biesty
|
| Guidelines Development Group: |
The Guideline Development Group (GDG) oversees the development process.
|
Email enquiries
Provisional schedule
| Scoping workshop: |
31 March 2010 |
| Consultation on draft scope with stakeholders: |
23 April - 21 May 2010
|
| Consultation on draft guideline with stakeholders: |
2 December 2011 - 27 January 2012
|
| Pre-publication check: |
12 April 2012 - 03 May 2012 |
| Publication date: |
June 2012 |
Project history
| Date |
Update |
| 30 January 2012 |
Consultation on the draft of the guideline is complete and the guideline is being modified in the light of comments received. |
| 22 July 2010 |
The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process. |
| 22 July 2010 |
The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. |
| 22 July 2010 |
Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline. Please see timescales above for dates of consultation with stakeholders. |
|
Key documents
This page was last updated: 30 January 2012
